2026-03-02T15:31:11-06:00 2025-06-30 520959934 ELLIN & TUCKER CHARTERED 400 EAST PRATT ST SUITE 200 BALTIMORE MD 21202 990 2024-07-01 742966731 SAN ANTONIO EYE BANK SANA 2106141209 9150 HUEBNER ROAD 105 SAN ANTONIO TX 78240 KENNETH J MAVERICK MD CHAIRMAN 2106141209 2026-02-17 1 0 CHANDINI SHAH P02176326 4107275735 2026-02-17 2024 2025-03-06 01:10:19Z KENNETH J MAVERICK MD 9150 HUEBNER ROAD 105 SAN ANTONIO TX 78240 4802747 0 X HTTPS://SAEYEBANK.ORG X 1965 TX RECOVERY, PROCESSING, AND DISTRIBUTION OF EYE TISSUE FOR TRANSPLANTATION. 10 10 0 16 0 0 13279 17508 4081837 4268298 508963 505616 0 0 4604079 4791422 12500 12500 0 0 2685344 2912573 0 0 17144 1538837 1728396 4236681 4653469 367398 137953 9940956 11949308 1461470 3055914 8479486 8893394 RECOVERY, PROCESSING AND DISTRIBUTION OF EYE TISSUE FOR TRANSPLANTATION. 0 0 3233818 7200 4268298 MEDICAL SERVICES OF EYE BANKING (INCLUDING THE RECOVERY, PROCESSING, ANALYSIS, TESTING AND DISTRIBUTION OF DONATED CADAVERIC TISSUES) FOR TRANSPLANTATION. 154297 1100 RESEARCH - PROVIDING TISSUES FOR MEDICAL RESEARCH. THE EYE BANK DONATES EYE TISSUE FOR TRANSPLANTS, RESEARCH AND TEACHING FOR WHICH THEY INCUR PROCESSING COSTS. THEY SOMETIMES RECEIVE MINIMAL REIMBURSEMENT FOR THESE SERVICES. 544329 4200 PUBLIC HEALTH EDUCATION - EYE AND TISSUE DONOR OUTREACH AND DONOR ADVOCACY. 3932444 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 10 10 1 0 0 0 0 0 0 1 1 0 0 0 0 0 0 1 0 0 TX X ANNIE THOMPSON 2064147182 1200 6TH AVE STE 300 SEATTLE WA 98101 LT COL MATTHEW C CALDWELL MD MEDICAL DIRECTOR 1.00 X X 0 0 0 KENNETH J MAVERICK MD CHAIRMAN 1.00 X X 0 0 0 DANIEL JOHNSON MD DIRECTOR 1.00 X 0 0 0 CHARISMA EVANGELISTA MD DIRECTOR 1.00 X 0 0 0 LISA MARTEN MD DIRECTOR 1.00 X 0 0 0 JAMES OLIVEROS DIRECTOR 1.00 X 0 0 0 JULIE C TSAI MD DIRECTOR 1.00 X 0 0 0 FERNANDO TRUJILLO MD DIRECTOR 1.00 X 0 0 0 JAMES LEHMANN MD DIRECTOR 1.00 X 0 0 0 ARLO C TERRY MD DIRECTOR 1.00 X 0 0 0 JIM S WAGNER EXECUTIVE DIRECTOR 40.00 X 199638 0 38642 199638 0 38642 1 0 1 0 CORNEAGEN LLC 1200 6TH AVE STE 300 SEATTLE WA 98101 ADMINISTRATIVE SVCS 240000 1 17508 17508 TISSUE PROCESSING 541990 4268298 4268298 4268298 410979 410979 105962 11325 94637 94637 94637 4791422 4268298 0 505616 X 12500 12500 247081 239560 6148 1373 1971224 1911225 49046 10953 53213 34804 18409 486784 329733 157051 154271 106447 47824 156 98 56 2 26600 26600 73576 73576 470754 230754 240000 31989 31989 50498 37995 12186 317 14793 12574 2219 176700 150195 26505 54349 41902 12152 295 1190 1190 57060 41233 15797 30 22583 14114 8130 339 PROGRAM SUPPLIES 691118 687672 0 3446 PROGRAM SHIPPING 47960 42203 5368 389 MISCELLANEOUS 9070 6256 2814 0 4653469 3932444 703881 17144 34692 19421 169251 106416 12434 17994 1076965 1003832 111905 73133 9344446 10046174 268228 1686170 9940956 11949308 282659 339986 1178811 2715928 1461470 3055914 X 8479486 8893394 8479486 8893394 9940956 11949308 137953 275955 0 X X 0 1 X 1 0 X 302272 10569 44870 13279 17508 388498 3821348 4293240 3977297 4081837 4268298 20442020 4123620 4303809 4022167 4095116 4285806 20830518 0 1728655 1820762 1611642 2018628 1491660 8671347 1728655 1820762 1611642 2018628 1491660 8671347 12159171 176092 196061 288231 381244 410979 1452607 176092 196061 288231 381244 410979 1452607 4299712 4499870 4310398 4476360 4696785 22283125 0.54570 0.54070 0.06520 0.05950 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 546261 543536 2725 530704 460296 70408 73133 OTHER CURRENT RECEIVABLE 59130 DEPOSITS 9566 NET RIGHT OF USE ASSETS 1617474 1686170 DUE TO CORNEAGEN LLC 1112889 OPERATING LEASE LIABILITY 1603039 2715928 X 4998860 275955 275955 4722905 68517 68517 4791422 4584952 0 4584952 68517 68517 4653469 PART X, LINE 2: THE EYE BANK FOLLOWS THE PROVISIONS OF ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES UNDER THE INCOME TAXES TOPIC OF THE CODIFICATION. THE CODIFICATION REQUIRES THE EYE BANK'S EVALUATION OF TAX POSITIONS, WHICH INCLUDE MAINTAINING ITS TAX-EXEMPT STATUS AND THE TAXABILITY OF ANY UNRELATED BUSINESS INCOME, AND DOES NOT ALLOW RECOGNITION OF TAX POSITIONS WHICH DO NOT MEET A "MORE-LIKELY-THAN-NOT" THRESHOLD OF BEING SUSTAINED BY THE APPLICABLE TAX AUTHORITY. MANAGEMENT DOES NOT BELIEVE IT TOOK ANY TAX POSITIONS THAT WOULD NOT MEET THIS THRESHOLD. 1 THE UNIVERSITY OF TEXAS HEALTH SAN ANTONIO DEPARTMENT OF OPHTHALMOLOGY 7703 FLOYD CURL DRIVE SAN ANTONIO TX 78229 741586031 501 (C)(3) 10000 0 SUPPORT DEPARTMENT OPHTHALMOLOGY RESIDENTS' TRAINING/EDUCATION PROGRAM 1 PART I, LINE 2: GRANTS ARE PAID DIRECTLY TO COLLEGES AND UNIVERSITIES IN THE UNITED STATES. X 0 0 0 0 0 0 0 0 0 JIM S WAGNER EXECUTIVE DIRECTOR 178698 0 19496 0 1444 0 9055 0 29587 0 238280 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 KENNETH J MAVERICK MD AND JAMES LEHMANN MD - BUSINESS RELATIONSHIP FORM 990, PART VI, SECTION B, LINE 11B FORM 990 REVIEW PROCESS AN INDEPENDENT ACCOUNTING FIRM PREPARES THE FORM 990. THE EXECUTIVE DIRECTOR BASED ON SITE WITH THE REPORTING ORGANIZATION IS PROVIDED THE RETURN PRIOR TO FILING FOR COMMENTS AND REVIEW. THE AUTHORIZED DIRECTOR/OFFICER OF THE GOVERNING BOARD OF DIRECTORS FOR THE REPORTING ORGANIZATION REVIEWS AND SIGNS THE FORM 990 PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 15A PROCESS OF DETERMINING COMPENSATION THE MANAGING ORGANIZATION, CORNEAGEN LLC, IN CONSULTATION WITH THE CHAIRMAN OF THE GOVERNING BOARD OF DIRECTORS OF THE REPORTING ORGANIZATION DETERMINES THE COMPENSATION OF THE EXECUTIVE DIRECTOR AND IN TURN THE MANAGEMENT COMPANY AND THE EXECUTIVE DIRECTOR WILL DETERMINE COMPENSATION LEVELS FOR OTHER INDIVIDUALS STATIONED ONSITE. AN ANNUAL, FORMAL APPRAISAL SYSTEM IS USED TO DETERMINE CHANGES TO COMPENSATION FOR THE EXECUTIVE DIRECTOR AND OTHER STAFF. FORM 990, PART VI, SECTION C, LINE 19 THE REPORTING ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND FINANCIAL INFORMATION AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G REFERRAL SERVICES: PROGRAM SERVICE EXPENSES 118,363. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 118,363. MEDICAL REVIEW: PROGRAM SERVICE EXPENSES 112,391. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 112,391. OPERATIONAL SERVICE FEE TO CORNEAGEN LLC: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 240,000. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 240,000. PART XII, LINE 2C THE PROCESS REGARDING THE PREPARATION OF THE AUDITED FINANCIAL STATEMENTS IS UNCHANGED FROM THE PRIOR YEAR.